Is Schizophrenia Nature or Nurture? Both Play a Role

Schizophrenia is neither purely genetic nor purely environmental. Twin studies estimate its heritability at roughly 79%, meaning that most of the variation in who develops the disorder traces back to DNA, but that still leaves a sizable share attributable to life experiences, infections, stress, and other non-genetic exposures. The real story is that genes load the gun and environment pulls the trigger, and increasingly, research points to specific molecular mechanisms that let those two forces talk to each other.

What Twin Studies Actually Show

The strongest evidence for a genetic contribution comes from twin research. If schizophrenia were entirely genetic, identical twins (who share virtually all their DNA) would always develop it together. They don’t. A nationwide Danish twin register study found that when one identical twin has schizophrenia, the other develops it about 33% of the time. For non-identical twins, who share roughly half their DNA, that concordance drops to about 7%.¹ From those numbers, researchers calculate a heritability of about 79%. When the definition is broadened to include related conditions on the schizophrenia spectrum, the heritability is similar, around 73%.

That 33% concordance figure is informative in two directions. It confirms a strong genetic influence (the rate is nearly five times higher than in non-identical twins), yet it also proves that genes are not destiny. Two people with identical DNA have only a one-in-three chance of sharing the diagnosis. Something beyond the genome must be deciding who crosses the threshold into illness and who does not.

Hundreds of Genes, Not One

Unlike conditions caused by a single gene mutation, schizophrenia arises from the combined small effects of hundreds or even thousands of genetic variants scattered across the genome. Researchers capture this through what is called a polygenic risk score, essentially a tally of how many risk-associated variants a person carries and how strongly each one contributes. These scores predict real outcomes: in a study combining four clinical cohorts, people with lower polygenic risk scores were roughly twice as likely to respond well to antipsychotic treatment during their first episode of psychosis compared with those carrying higher scores.²

Genome-wide association studies across different populations continue to identify new risk locations in DNA. A Korean study, for example, found a previously unreported variant linked to a gene involved in brain cell signaling, and showed that combining data from both East Asian and European populations improved the ability to predict risk in Korean samples.³ This matters because it underscores that schizophrenia genetics are not confined to any one ancestry, and that combining diverse datasets gives a clearer picture of genetic risk worldwide.

On top of these many common variants, a small fraction of cases involve larger structural changes in DNA called copy number variations, where whole chunks of a chromosome are deleted or duplicated. These occur in roughly 3.5 to 5% of people with schizophrenia and confer much bigger individual risk boosts than any single common variant.⁴ Yet even these large deletions are not fully “penetrant,” meaning many people carry them without ever developing psychosis. Healthy individuals carry some of the same structural changes, which highlights how much the surrounding genetic and environmental context matters.⁵

What Happens Before Birth

Some of the strongest environmental risk factors operate before a child is even born. When a pregnant person’s immune system is activated by an infection, the resulting inflammation can affect fetal brain development. Exposure to influenza during the first trimester of pregnancy has been linked to a roughly sevenfold increase in the offspring’s later risk of schizophrenia, and exposure during the transition from the first to second trimester to a threefold increase.⁶ The parasite Toxoplasma gondii also matters here: offspring born to mothers with higher antibodies against it showed about twice the risk. These are large relative increases, though it is important to remember they are applied against a low baseline risk, so the absolute number of affected individuals remains small.

Paternal age adds another wrinkle. Older fathers pass on more new mutations to their children, and a study using parent-child genetic data estimated that offspring of a 45-year-old father face about a 9% higher risk of schizophrenia compared with offspring of a 25-year-old father, based purely on the accumulation of new mutations.⁷ Interestingly, the actual increase in risk seen in population data was larger than what new mutations alone could explain, suggesting that other factors correlated with later fatherhood, perhaps social or psychological ones, also play a role.

Childhood Trauma as a Turning Point

After birth, childhood adversity stands out as one of the most studied environmental contributors. A systematic review concluded that childhood trauma is likely the single most important environmental factor associated with schizophrenia, and that psychotic symptoms in people with a history of abuse tend to be more severe, more persistent, and harder to treat.⁸ This fits with the “neural diathesis-stress model,” which proposes that severe stress acts on an existing vulnerability, tipping someone who might otherwise have remained well into active illness.⁹

The link between trauma severity and symptom severity appears to follow a dose-response pattern. In one study of people with schizophrenia, the total number of different types of childhood trauma experienced was strongly correlated with the overall severity of psychotic symptoms, including negative symptoms like emotional withdrawal and general psychopathology.¹⁰ More types of trauma, worse illness. That dose-response relationship makes a strong case that the connection is not just coincidence.

Growing Up in Cities

Being raised in a densely populated urban area is consistently associated with higher rates of schizophrenia. A large Danish study found a dose-response relationship: the more years a person spent in a highly urbanized area during childhood and adolescence, the greater the risk. People who lived their first 15 years in the most urban category had roughly 2.75 times the risk of schizophrenia compared with those raised in more rural settings.¹¹ Moving to a less urban area was associated with reduced risk, and moving to a more urban one with increased risk, adding further weight to the idea that environment matters independent of genetics.

What is it about cities? No one has pinpointed a single factor, but neuroimaging research offers clues. A study of healthy adults found that growing up in a city was associated with reduced gray matter volume in a brain region involved in executive function and emotion regulation. In men specifically, urban upbringing also correlated with structural differences in a stress-processing area of the brain that had previously been linked to social stress responses.¹² These findings suggest that chronic exposure to urban stressors during development may physically reshape brain architecture in ways that increase vulnerability.

Urban birth and childhood trauma may also interact with cognitive development. One study found that being born in an urban area tripled the odds of a first episode of schizophrenia, and that roughly half of that effect was mediated through lower IQ scores.¹³ This points to a chain of influence: urban environments may subtly impair neurodevelopment, which in turn raises the odds of crossing into psychosis.

Social Defeat, Migration, and Minority Stress

One of the more striking findings in schizophrenia epidemiology is that immigrants and ethnic minorities show elevated rates of psychotic disorders, even when they move to rural areas rather than cities. In a study conducted in the relatively rural east of England, people of Black African origin had roughly four times the rate of first-episode psychosis compared with the white British population, and people of Black Caribbean origin about 4.6 times the rate. Pakistani-origin individuals showed about 2.3 times the rate.¹⁴ These differences persisted after adjusting for other risk factors, which argues against a purely genetic explanation and points toward social and environmental stressors unique to minority status.

The “social defeat hypothesis” offers a framework for understanding these patterns. It proposes that chronic experiences of exclusion, discrimination, and outsider status can sensitize the brain’s dopamine system, the same neurotransmitter pathway most directly implicated in psychosis.¹⁵ According to this model, repeated social rejection does not just feel bad; over time it chemically remodels the brain’s reward and salience circuits in ways that make psychotic experiences more likely.¹⁶ The hypothesis helps explain why diverse groups, immigrants, visible minorities, people living in poverty, and even those with childhood histories of bullying all share an elevated risk.

Cannabis and Other Substance Triggers

Cannabis use during adolescence and young adulthood has been consistently linked to higher rates of psychotic disorders in longitudinal studies that control for other drug use and pre-existing risk factors.¹⁷ An updated systematic review found that both high-frequency and low-frequency marijuana use were associated with a significantly increased risk of schizophrenia.¹⁸ The relationship appears to be genuinely causal rather than merely a case of people who are already predisposed seeking out drugs, though genetic vulnerability certainly amplifies the effect. Cannabis during the teenage years, when the brain is still undergoing major developmental changes, seems to be a particularly risky exposure for those already carrying genetic susceptibility.

Where Genes and Environment Physically Meet

The idea that genes and environment interact is not just a conceptual hand-wave. Researchers have identified specific genes whose effects change depending on a person’s life experiences. Systematic reviews point consistently to three gene families: COMT (involved in breaking down dopamine), BDNF (a protein important for brain cell growth and survival), and FKBP5 (involved in the body’s stress response). Variations in these genes appear to interact with early life stress and cannabis use, influencing the likelihood and severity of schizophrenia-spectrum disorders.¹⁹

The FKBP5 gene is especially interesting because it provides a plausible molecular pathway linking childhood adversity to brain changes. Research examining gene expression in brain tissue has found support for a model in which FKBP5 variants alter how the stress-response system calibrates itself after early trauma, essentially locking the system into a state of heightened reactivity.²⁰ This is where the nature-nurture question stops being a debate and starts being molecular biology: the same gene can be harmless or harmful depending on what happened to you as a child.

Epigenetics provides the broader mechanism through which this happens. Environmental exposures can add or remove chemical tags on DNA without altering the genetic sequence itself, changing which genes are turned on or off. In schizophrenia, altered patterns of these chemical tags have been found across the genome, and researchers increasingly view epigenetics as the bridge between inherited genetic risk and the environmental insults that activate it.²¹

The Two-Hit Model

Many researchers now favor a “two-hit” framework for understanding schizophrenia. The first hit is an early disruption, often prenatal, such as maternal infection or severe stress, that subtly alters brain development. The second hit comes later, typically during adolescence or early adulthood, in the form of additional stressors like trauma, drug use, or social adversity. Neither hit alone is enough to produce full-blown psychosis in most people, but together they can push a vulnerable brain past its tipping point.²²

Animal experiments have tested this directly. In one study, mice were exposed to a simulated viral infection before birth (the first hit) and then subjected to unpredictable stress during the equivalent of puberty (the second hit). Only the combination of both exposures produced significant behavioral abnormalities resembling features of psychosis, including heightened sensitivity to drugs that mimic psychotic states.²³ The same study found that early treatment with an anti-inflammatory drug could prevent these behavioral changes from emerging, which is provocative evidence that the inflammatory pathway connecting the two hits could be a target for prevention.

Synaptic Pruning and the C4 Gene

One of the most celebrated genetic discoveries in schizophrenia came in 2016, when researchers showed that the strongest genetic association with the disorder, located in a highly complex region of the genome, could be traced largely to structural variants in a gene called C4. This gene is part of the complement system, a branch of the immune system that, in the brain, helps tag and eliminate unnecessary connections between neurons during adolescence, a process called synaptic pruning. People whose C4 gene variants produce higher levels of C4A protein in the brain have a proportionally higher risk of schizophrenia.²⁴

In mouse experiments, overexpression of C4 led to about a 16% reduction in synaptic density on certain types of brain cells, suggesting that too much C4 literally strips away too many neural connections.²⁵ Postmortem studies of human brains have confirmed altered complement activity across multiple brain regions in people with schizophrenia.²⁶ This could explain a long-standing puzzle: why schizophrenia typically emerges in late adolescence and early adulthood, precisely when synaptic pruning is at its peak. If the pruning process is genetically set to be too aggressive, the developing brain may lose connections it needs.

Toxoplasma gondii, the Cat Parasite

The link between the parasite Toxoplasma gondii and schizophrenia has drawn considerable attention. A systematic review and meta-analysis found that testing positive for Toxoplasma antibodies roughly doubled the odds of having schizophrenia.²⁷ A 2025 study added a twist: it found that markers of newer or reactivating Toxoplasma infection were associated with worse symptom severity in people who already had chronic schizophrenia, and that the association was strongest in patients experiencing their first psychotic episode.²⁸

In animals, Toxoplasma infection alters behavior and neurotransmitter function in ways that mirror some features of psychosis. Out of 19 studies comparing Toxoplasma antibodies in people with severe psychiatric disorders versus controls, 18 reported higher rates in the affected group.²⁹ Whether the parasite is a true cause, a contributing factor in a subset of cases, or a marker for some broader immune vulnerability remains an open question, but the consistency of the association across dozens of studies spanning decades makes it hard to dismiss.

The Gut Microbiome as an Emerging Factor

A newer line of research focuses on the trillions of bacteria living in the gut and their communication with the brain. Studies have found significant differences in the gut microbiome composition of people with schizophrenia compared with healthy controls, and some of these differences correlate with symptom severity and cognitive function.³⁰ A Mendelian randomization study, which uses genetic variation as a natural experiment to test causal direction, found evidence that certain bacterial families were more abundant in people with schizophrenia and identified potential mediating pathways involving inflammation, gut barrier integrity, and metabolism.³¹ This research is still early, but it adds another environmental layer that could interact with genetic risk in ways we are only beginning to map.

When Genetic Risk Does Not Mean Illness

An underappreciated finding is that carrying a high genetic burden for schizophrenia does not always end in a diagnosis. In people who never develop psychosis, a higher polygenic risk score for schizophrenia was associated with modestly higher levels of openness to experience, one of the major personality traits.³² In other words, some of the same genetic variants that increase schizophrenia risk may, in the absence of the environmental triggers needed to push someone into illness, express themselves as personality quirks rather than pathology. This resonates with the longstanding observation that creativity and unconventional thinking sometimes run in the same families as schizophrenia.

Why Schizophrenia Looks Different Around the World

If both nature and nurture matter, you would expect the course of schizophrenia to vary across cultures, and it does. The World Health Organization’s International Pilot Study of Schizophrenia found that patients in developing countries had, on average, considerably better outcomes over a two-year follow-up than patients in developed countries, even when diagnosed using the same standardized criteria.³³ Part of this variation was linked to factors like social isolation and type of symptom onset, but a large portion remained unexplained by the variables researchers typically measure. Extended family structures, greater community integration, and lower emphasis on individual achievement have all been proposed as buffers, though the exact mechanisms are still debated. The cross-cultural data is a humbling reminder that “environment” extends well beyond measurable biological exposures to include the social fabric surrounding the person.

The Evolutionary Puzzle

If schizophrenia reduces reproductive success, as it demonstrably does, why hasn’t natural selection wiped out the genetic variants that cause it? This “evolutionary paradox” has generated several theories. Schizophrenia occurs at roughly 1% of the population worldwide, and its heritability is around 70 to 80%, yet the genetic variants associated with it persist generation after generation.³⁴ One leading explanation is that the same variants confer subtle advantages in people who carry some of them without developing the full disorder. This is consistent with the personality-trait finding mentioned above: a moderate genetic load might enhance creativity or cognitive flexibility, while a heavy load, particularly combined with environmental adversity, tips into disease.³⁵ Another possibility is that many of the relevant variants are under recent negative selection but have not yet been eliminated simply because evolution is slow relative to the number and diversity of risk alleles involved.